ecosystem / companies / supermoon-capital
Supermoon Capital logo

Supermoon Capital

Supermoon Capital is a San Francisco venture firm that invests only in sleep and circadian health, writing pre-seed and seed cheques worldwide. Mike Masterson, Pat Connolly and Grayson Judge launched it in August 2021 with a US$36 million first fund backed by ResMed. Its portfolio page lists 24 companies, among them Endel and Big Health.

Venture capitalSan FranciscoFounded 2021supermooncapital.com ↗
US$36Mfirst fund, announced 25 August 2021, with ResMed among its investorsSupermoon Capital launch release, 2021-08-25 ↗
24companies on the firm's portfolio pagesupermooncapital.com, read 2026-10-13 ↗

The people

Mike MastersonCo-founder and Managing Partner, Supermoon Capital · 1 TechTO talk
PC
Pat ConnollyCo-founderprofile coming
GJ
Grayson JudgeCo-founderprofile coming

Open roles via the TechTO Job Board

Working at Supermoon Capital

Browse open roles across the community on the TechTO Job Board — Canada’s most connected tech network. Supermoon Capital’s roles show up here whenever they post.

Open roles on the TechTO Job Board ↗Or their own careers page: supermooncapital.com/careers ↗

Jobs live on jobs.techto.org — the only structured source. We link to it rather than scraping career sites, so the board is always the source of truth.

On the TechTO stage

Every talk is searchable — ask the archive about Supermoon Capital ↗

About

Supermoon's premise is that sleep is a very large market that has been little studied and less invested in. Co-founder Mike Masterson told TechTO in October 2026 that the idea came from partner Pat Connolly, who spent nearly four decades at Williams-Sonoma and saw fast growth in anything bedroom-related, around the time Whoop, Oura and the Apple Watch arrived. The firm says it is accelerating innovation in sleep and circadian health, and backs founders from software, hardware and life sciences.

The firm launched publicly on 25 August 2021 with a first fund of US$36 million and ResMed, the sleep apnea device maker, as a named investor. Masterson said on stage that the partners had started work in 2019, that the largest strategic investor in sleep joined at the first fund's final close, and that Supermoon recently held a first close on its second fund; no second fund has been announced in writing.

Supermoon is not a Canadian firm. It appears here because Masterson spoke on the TechTO stage.

Backers

ResMed is the named investor in the US$36 million first fund (launch release, 2021-08-25). Other limited partners are not disclosed.

More from TechTO ×2

Quick answers

What does Supermoon Capital invest in?

Only sleep and circadian health, at pre-seed and seed, anywhere in the world. Its portfolio includes Endel, EnsoData, Mosanna Therapeutics, Big Health and Arcascope.

Who founded it?

Mike Masterson, Pat Connolly and Grayson Judge. The launch release of 25 August 2021 names all three as co-founders and managing partners.

How big is the fund?

The first fund was US$36 million, announced in August 2021. Masterson told TechTO in October 2026 that a second fund had held a first close; its size has not been published.

Who from Supermoon Capital has spoken at TechTO?

Mike Masterson, in October 2026, on the mistakes founders make when pitching investors and what raising a fund in a new category taught him.

Suggest an edit
Work here? Claim this page
Know someone who belongs here? Suggest a profile
Maintained by TechTO · facts sourced and dated · last reviewed Oct 13, 2026